Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by G.T. Wondrak
551 Targeting the Redox Vulnerability of V600E BRAF-mutated Malignant Melanoma Cells Using the Electron Transfer Reactant PMS (Phenazine Methosulfate) as a Mitochondria-Directed Chemotherapeutic
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Related publications
Metformin Accelerates the Growth of BRAF V600E -Driven Melanoma by Upregulating VEGF-A
Cancer Discovery
Oncology
Targeting the Cellular Signaling: BRAF Inhibition and Beyond for the Treatment of Metastatic Malignant Melanoma
Dermatology Research and Practice
Dermatology
Development of Encorafenib for BRAF-mutated Advanced Melanoma
Current Opinion in Oncology
Cancer Research
Oncology
BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells
Clinical Cancer Research
Cancer Research
Oncology
LETTER TO THE EDITOR: Management of Vemurafenib Induced Severe Arthralgia and Pyrexia in a Patient With BRAF V600E Mutated Melanoma: First Experience With a Switch to Dabrafenib
Open Dermatology Journal
Dermatology
OA12.06 Mutational Landscape of BRAF V600E Positive Lung Cancer Patients Following BRAF Directed Therapy Failure
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Targeting Epigenetics for Treatment of BRAF Mutated Metastatic Melanoma With Decitabine in Combination With Vemurafenib: A Phase Lb Study
Oncotarget
Oncology
Comparison of Testing Methods for the Detection of BRAF V600E Mutations in Malignant Melanoma: Pre-Approval Validation Study of the Companion Diagnostic Test for Vemurafenib
PLoS ONE
Multidisciplinary
Correction: Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma
PLoS ONE
Multidisciplinary
